Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vanadro is a private drug development consulting company focused on clinical pharmacology, pharmacometrics, regulatory strategy, and broader drug development support for biopharma clients. The firm supports programs from preclinical development through IND-enabling work and clinical development, with particular experience in immuno-oncology. Its consulting scope spans small molecules, biologics, cell therapies, and antibody-drug conjugates, and includes modeling and simulation, PK/PD analysis, due diligence, and interactions with global health authorities. Vanadro appears to operate as a services business rather than a therapeutic product developer with its own disclosed internal pipeline. The company is led by founder and CEO Dr. Sanela Bilic and is based in Iowa.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vanadro Consulting.